GS
EW icon

GAM Systematic’s Edwards Lifesciences EW Stock Holding History

GAM Systematic’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,783
Closed -$306K – 614
2016
Q4 		$306K Sell
9,783
-17,427
-64% -$565K 0.07% 422
2016
Q3 		$1.09M Buy
27,210
+1,473
+6% +$55.5K 0.23% 158
2016
Q2 		$856K Sell
25,737
-18,390
-42% -$629K 0.21% 196
2016
Q1 		$1.3M Buy
44,127
+12,900
+41% +$356K 0.34% 75
2015
Q4 		$822K Sell
31,227
-40,635
-57% -$1.06M 0.23% 164
2015
Q3 		$1.7M Sell
71,862
-165,246
-70% -$3.99M 0.39% 32
2015
Q2 		$5.63M Buy
237,108
+116,616
+97% +$2.63M 0.71% 19
2015
Q1 		$2.86M Buy
120,492
+1,716
+1% +$38.5K 0.39% 90
2014
Q4 		$2.52M Buy
+118,776
New +$2.39M 0.51% 48

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GAM Systematic's EW Position: Q1 2017 in Review

GAM Systematic sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 9,783 shares — an estimated $306K sold.

GAM Systematic first reported a position in EW in Q4 2014 and held it in 9 quarters. The position peaked at $5.63M in Q2 2015. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • GAM Systematic reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
  • GAM Systematic sold 9,783 Edwards Lifesciences shares in Q1 2017, an estimated $306K.
  • GAM Systematic first reported a position in Edwards Lifesciences in Q4 2014 and held it in 9 quarters.
  • GAM Systematic's Edwards Lifesciences position peaked at $5.63M in Q2 2015.
  • 691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on GAM Systematic's 13F filing for Q1 2017, filed 15 May 2017.